Kintsugi has chosen to name 2022 Gartner Cool Vendor in AI Governance and Responsible AI

Berkeley, California – () –Kintsugia Gulf-based startup developing vocal biomarker technology to detect signs of depression and anxiety from short speech segments, has been awarded the 2022 Gartner Cool Vendor Award in AI Governance and Responsible AI – an annual award that recognizes innovative, impactful, and interesting startups.

Kintsugi is developing machine learning algorithms that analyze short segments of free speech for vocal features that correlate with clinical depression and anxiety. Their API platform Kintsugi Voice provides clinical decision support for healthcare practitioners, by recording patients’ mental health in real time. The tool integrates seamlessly with clinical call centers, telehealth platforms, and remote patient monitoring applications.

The Gartner report highlights that Kintsugi Voice does not rely on question-and-answer methods to assess a user’s mental health, nor does it rely on natural language processing, because it analyzes how people speak, not the content of their speech. Moreover, this allows them to work in any language.

The machine learning model is based on the world’s largest dataset of vocal biomarkers and mental health. Collected from Kintsugi’s award-winning consumer health app in over 250 international cities and in multiple languages. The startup leverages this unique and ever-evolving large global data set to prevent bias and push for responsible AI in healthcare. Moreover, it works to expand its reach through the dissemination of Kintsugi Voice in different patient groups, through clinical partnerships with a number of hospitals and health organizations.

According to Gartner, companies that are great sellers in AI governance and responsible AI are those that develop tools that ensure AI fairness, bias mitigation, explainability, privacy, and compliance.

“We are delighted to be recognized as Gartner Cool Vendor,” said Grace Chang, founder and CEO of Kintsugi. “Mental health cases are on the rise, and are identified only by primary care practitioners 47.3% of the time. We aim to support providers with objective and accurate insights into mental health, so they can ensure their patients get the care they need.”

Kintsugi recently announced a $20 million Series A, raising the company’s total capital to $28 million since its inception in 2019. The funding round was led by New York-based global venture capital firm Insight Partners, and will advance Kintsugi’s mission to expand Access to mental health care for more in need.

This is the latest in a series of awards for the startup, which was shortlisted for Forbes’ 2022 AI 50 in North America, and received the Frost & Sullivan Best Technology Innovation Leadership Award for 2022.

About Kintsugi:

Kintsugi is developing a new vocal biomarker software to detect signs of clinical depression and anxiety from short clips of free speech, bridging mental health care gaps across risky health systems, and saving time and lives. Headquartered in Berkeley, California, Kintsuji is on a mission to provide equitable access to mental health care for all.

About Gartner:

Gartner, Inc. offers (NYSE: IT) An objective and actionable vision for CEOs and their teams. Its expert guidance and tools enable faster, smarter decision making and stronger performance on the organization’s mission priorities. To learn more, visit

Gartner Disclaimer:

Gartner does not endorse any vendor, product, or service mentioned in our research publications, and does not advise technology users to select vendors with the highest ratings or other designations. Gartner’s research publications consist of the opinions of Gartner Research and should not be construed as factual statements. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Leave a Comment